<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/67B34D05-3A52-4A09-8FF9-F2398D60E246"><gtr:id>67B34D05-3A52-4A09-8FF9-F2398D60E246</gtr:id><gtr:name>University of Surrey</gtr:name><gtr:address><gtr:line1>Registry</gtr:line1><gtr:line2>Stag Hill</gtr:line2><gtr:line4>Guildford</gtr:line4><gtr:line5>Surrey</gtr:line5><gtr:postCode>GU2 7XH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/86BA0D2C-1895-41C5-B18C-092178DFFB3E"><gtr:id>86BA0D2C-1895-41C5-B18C-092178DFFB3E</gtr:id><gtr:name>National Institute for Health Research</gtr:name><gtr:address><gtr:line1>NIHR Clinical Research Network CC</gtr:line1><gtr:line2>Fairbairn House</gtr:line2><gtr:line3>71-75 Clarendon Road</gtr:line3><gtr:postCode>LS2 9PH</gtr:postCode><gtr:region>Yorkshire and the Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/54D56780-2B14-499B-B2D8-660CF80EE6A7"><gtr:id>54D56780-2B14-499B-B2D8-660CF80EE6A7</gtr:id><gtr:name>PhytoQuest Ltd</gtr:name><gtr:address><gtr:line1>Plas Gogerddan</gtr:line1><gtr:postCode>SY23 3EB</gtr:postCode><gtr:region>Wales</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/29A671C9-96A0-4955-B890-76F05D83EE0D"><gtr:id>29A671C9-96A0-4955-B890-76F05D83EE0D</gtr:id><gtr:name>Medtronic</gtr:name><gtr:address><gtr:line1>710 Medtronic Parkway</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5D157790-D5A2-44E4-BCC3-24A8FDF74625"><gtr:id>5D157790-D5A2-44E4-BCC3-24A8FDF74625</gtr:id><gtr:name>Kymab</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/67B34D05-3A52-4A09-8FF9-F2398D60E246"><gtr:id>67B34D05-3A52-4A09-8FF9-F2398D60E246</gtr:id><gtr:name>University of Surrey</gtr:name><gtr:address><gtr:line1>Registry</gtr:line1><gtr:line2>Stag Hill</gtr:line2><gtr:line4>Guildford</gtr:line4><gtr:line5>Surrey</gtr:line5><gtr:postCode>GU2 7XH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/86BA0D2C-1895-41C5-B18C-092178DFFB3E"><gtr:id>86BA0D2C-1895-41C5-B18C-092178DFFB3E</gtr:id><gtr:name>National Institute for Health Research</gtr:name><gtr:address><gtr:line1>NIHR Clinical Research Network CC</gtr:line1><gtr:line2>Fairbairn House</gtr:line2><gtr:line3>71-75 Clarendon Road</gtr:line3><gtr:postCode>LS2 9PH</gtr:postCode><gtr:region>Yorkshire and the Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/54D56780-2B14-499B-B2D8-660CF80EE6A7"><gtr:id>54D56780-2B14-499B-B2D8-660CF80EE6A7</gtr:id><gtr:name>PhytoQuest Ltd</gtr:name><gtr:address><gtr:line1>Plas Gogerddan</gtr:line1><gtr:postCode>SY23 3EB</gtr:postCode><gtr:region>Wales</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/29A671C9-96A0-4955-B890-76F05D83EE0D"><gtr:id>29A671C9-96A0-4955-B890-76F05D83EE0D</gtr:id><gtr:name>Medtronic</gtr:name><gtr:address><gtr:line1>710 Medtronic Parkway</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5D157790-D5A2-44E4-BCC3-24A8FDF74625"><gtr:id>5D157790-D5A2-44E4-BCC3-24A8FDF74625</gtr:id><gtr:name>Kymab</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A33E6551-92C3-4DBE-AB74-B4F4BA94D33B"><gtr:id>A33E6551-92C3-4DBE-AB74-B4F4BA94D33B</gtr:id><gtr:firstName>Paul Graham</gtr:firstName><gtr:surname>Hellewell</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_12022"><gtr:id>958863A1-C92D-4203-AFF4-34776DF3B5E9</gtr:id><gtr:title>Confidence in Concept 2012 - University of Sheffield</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_12022</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>The Confidence in Concept scheme is a key part of MRC?s translational research strategy and provides annual awards to institutions, to be used flexibly to support the earliest stages of multiple translational research projects. The award can be used by the institution to support a number of preliminary-stage translational projects. The projects supported should aim to provide sufficient preliminary data to establish the viability of an approach ?? before seeking more substantive funding.&amp;nbsp; It is intended to accelerate the transition from discovery research to translational development projects by supporting preliminary work or feasibility studies to establish the viability of an approach.</gtr:technicalSummary><gtr:fund><gtr:end>2015-07-01</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-01-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>360000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute for Health Research</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>NIHR Devices for Dignity Healthcare Technology Co-Operative</gtr:department><gtr:description>Collaborator on a project awarded under The University of Sheffield's institutional award from Round 1 of the Confidence in Concept Scheme</gtr:description><gtr:id>74696F02-9497-4A5D-A7B0-181EBE144BF2</gtr:id><gtr:impact>Intended outputs are currently confidential. This is a multi-discplinary project involving clinicians, engineers, bioscientists and market expertise and product design.</gtr:impact><gtr:outcomeId>5461e1f65830a2.65235537-1</gtr:outcomeId><gtr:partnerContribution>D4D's input adds a monetary contribution and expertise in target condition management and working with the NHS. D4D also provide market and intellectual property expertise.</gtr:partnerContribution><gtr:piContribution>Lead on a project looking at detecting early onset of urinary tract infection in patients.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Surrey</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaborator on a project awarded under The University of Sheffield's institutional award from Round 1 of the Confidence in Concept Scheme</gtr:description><gtr:id>FFA28515-C7BA-40E2-BE35-86CECDAB9E73</gtr:id><gtr:impact>Discussions are ongoing as to further outcomes.</gtr:impact><gtr:outcomeId>5461ef5f0b55c8.81028907-1</gtr:outcomeId><gtr:partnerContribution>Identification of a new programme of work to further develop project.</gtr:partnerContribution><gtr:piContribution>Lead project on development of a long-acting clotting factor to provide a prophylactic therapy for haemophiliac patients.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Kymab</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaborator on a project awarded under The University of Sheffield's institutional award from Round 1 of the Confidence in Concept Scheme</gtr:description><gtr:id>911386A9-6FFC-4F2A-BE22-0A84F571C0C9</gtr:id><gtr:impact>Partner on successful DPFS application.</gtr:impact><gtr:outcomeId>58c1690e58ffd7.36489010-1</gtr:outcomeId><gtr:partnerContribution>Developed monoclonal antibodies and partner on successful DPFS application.</gtr:partnerContribution><gtr:piContribution>Lead on a project developing Anti-OPG and TRAIL therapies for Pulmonary hypertension</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>PhytoQuest Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaborator on a project awarded under The University of Sheffield's institutional award from Round 1 of the Confidence in Concept Scheme</gtr:description><gtr:id>AA3337C3-AD7D-4008-9908-BA9E07661C5A</gtr:id><gtr:impact>None</gtr:impact><gtr:outcomeId>58c16a3ddfdef3.41069679-1</gtr:outcomeId><gtr:partnerContribution>Provided a set of natural compounds</gtr:partnerContribution><gtr:piContribution>Lead with developing small molecule channel modulators to treat polycystic kidney disease.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medtronic</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Collaborator on a project awarded under The University of Sheffield's institutional award from Round 1 of the Confidence in Concept Scheme</gtr:description><gtr:id>6108E12B-2281-4268-9295-E281DD166E15</gtr:id><gtr:impact>Presentation at TCT 2013 conference. Applications for further grants resulting in part from CiC funding are pending.</gtr:impact><gtr:outcomeId>5463604f8dcfe8.23836910-1</gtr:outcomeId><gtr:partnerContribution>In kind provision of cardiac stents</gtr:partnerContribution><gtr:piContribution>Lead and carry out a project on radiofrequency ablation for the treatment of pulmonary hypertension</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaborator on a project awarded under The University of Sheffield's institutional award from Round 1 of the Confidence in Concept Scheme</gtr:description><gtr:id>204C5475-FE92-47A3-8413-5A564721C3E6</gtr:id><gtr:impact>Collaborative opportunities are still under discussion.</gtr:impact><gtr:outcomeId>5461ed3a8e7fe5.84972396-1</gtr:outcomeId><gtr:partnerContribution>Input into new study ideas developing from CiC award.</gtr:partnerContribution><gtr:piContribution>Lead on a project to develop a new drug to inhibit viral-induced airway inflammation.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical Lectureship</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>4938A2BF-F87C-4EF9-9C45-E2A4F104446A</gtr:id><gtr:outcomeId>58c16b3f505c54.97437779</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1204230</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Grant</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/M004864/1</gtr:fundingRef><gtr:id>322B4F82-00B9-4037-BD3F-3F03070752CF</gtr:id><gtr:outcomeId>5461dbbc4c8e30.27087159</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1010100</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Senior Basic Science Research Fellowship</gtr:description><gtr:end>2018-11-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>FS/13/48/30453</gtr:fundingRef><gtr:id>6600C55C-A42D-4BB8-9829-1EB4DA33721A</gtr:id><gtr:outcomeId>5460dccd858ef6.52599043</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HC Roscoe Grant</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>British Medical Association (BMA)</gtr:fundingOrg><gtr:id>4AABB470-0C2E-4E7C-B619-9C426DC80D09</gtr:id><gtr:outcomeId>5461dcdfc57510.92740367</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>521681</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Developmental Pathway Funding Scheme</gtr:description><gtr:end>2016-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L023040/1</gtr:fundingRef><gtr:id>401EACA5-7C30-4DEA-8FAA-FD705EF77396</gtr:id><gtr:outcomeId>5460d1ba161ca0.13471454</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2401085</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Developmental Pathway Funding Scheme</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/M015491/1</gtr:fundingRef><gtr:id>A8CB97D2-4C83-4215-84AF-5A32E995F9FF</gtr:id><gtr:outcomeId>56ea90d3a19a93.54282188</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>The disclosure relates to agents that inhibit the activity of osteoprotegerin (OPG) and their use in the treatment of pulmonary hypertension.</gtr:description><gtr:grantRef>MC_PC_12022</gtr:grantRef><gtr:id>2CD75028-14AC-4CFA-9B87-E04F28D1083D</gtr:id><gtr:impact>Other patent application: EP2773668</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:outcomeId>58c16e092df492.64422262</gtr:outcomeId><gtr:patentId>US20140255404</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Developing therapies for Pulmonary Hypertension</gtr:title><gtr:yearProtectionGranted>2016</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>PH Therapeutics Limited</gtr:companyName><gtr:description>PH Therapeutics Ltd is a new business that intends to develop novel antibody therapies to treat the orphan disease Pulmonary Arterial Hypertension (PAH). The goal is to develop these new therapies to the clinic and to bring benefit to patients suffering from this rare and debilitating disease.</gtr:description><gtr:id>8CAB818D-C0DC-4F16-B9F4-AA22B3158582</gtr:id><gtr:impact>Through the work of Dr Allan Lawrie at the University of Sheffield, PH Therapeutics is developing novel antibody therapies that aim to reverse the progression of pulmonary arterial hypertension leading to improved treatments for patients.</gtr:impact><gtr:outcomeId>5461f2913fa4a7.01635320</gtr:outcomeId><gtr:url>http://phtherapeutics.com/</gtr:url><gtr:yearCompanyFormed>2013</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>63CE7388-30F3-4F4F-A7EC-3836F990C802</gtr:id><gtr:title>Synthesis and activity of a novel inhibitor of nonsense-mediated mRNA decay.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0dd916e90a056d236cb886bc3021fc98"><gtr:id>0dd916e90a056d236cb886bc3021fc98</gtr:id><gtr:otherNames>Gotham VJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn><gtr:outcomeId>5aa16ad8914479.90455080</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E60FE6F-34F7-4A7F-A6F8-6DE14469F98C</gtr:id><gtr:title>A zebrafish compound screen reveals modulation of neutrophil reverse migration as an anti-inflammatory mechanism.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9dc100207245abff54644860ce102ccf"><gtr:id>9dc100207245abff54644860ce102ccf</gtr:id><gtr:otherNames>Robertson AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>5460ce664f9c46.92530584</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA3D8CFB-A493-4195-A757-77CF5ACFADB4</gtr:id><gtr:title>Metal Complexes for Two-Photon Photodynamic Therapy: A Cyclometallated Iridium Complex Induces Two-Photon Photosensitization of Cancer Cells under Near-IR Light.</gtr:title><gtr:parentPublicationTitle>Chemistry (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f3330e98247f38d77b94815708404aa"><gtr:id>9f3330e98247f38d77b94815708404aa</gtr:id><gtr:otherNames>McKenzie LK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0947-6539</gtr:issn><gtr:outcomeId>5aa16ad8b63157.14958160</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5705C2D-066D-45B0-99A0-5E99C3017EB7</gtr:id><gtr:title>Pulmonary Artery Denervation Attenuates Pulmonary Arterial Remodeling in Dogs With Pulmonary Arterial Hypertension Induced by Dehydrogenized Monocrotaline.</gtr:title><gtr:parentPublicationTitle>JACC. Cardiovascular interventions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/240a27c7bd5d10365eaae398f59768ee"><gtr:id>240a27c7bd5d10365eaae398f59768ee</gtr:id><gtr:otherNames>Zhou L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1936-8798</gtr:issn><gtr:outcomeId>58c1640d2de574.50228470</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E433E10B-3417-4430-AB1B-60877CA89C41</gtr:id><gtr:title>Photodynamic killing of cancer cells by a Platinum(II) complex with cyclometallating ligand.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7e7912a2fb59657acd15264d6a5b16e"><gtr:id>a7e7912a2fb59657acd15264d6a5b16e</gtr:id><gtr:otherNames>Doherty RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58c164688f55b4.61753160</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8201FB2-AE00-4114-B745-09FC4BDC8B4A</gtr:id><gtr:title>Hemodynamic, functional, and clinical responses to pulmonary artery denervation in patients with pulmonary arterial hypertension of different causes: phase II results from the Pulmonary Artery Denervation-1 study.</gtr:title><gtr:parentPublicationTitle>Circulation. Cardiovascular interventions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06953a58f6e78f61b8d9ee43ca17e741"><gtr:id>06953a58f6e78f61b8d9ee43ca17e741</gtr:id><gtr:otherNames>Chen SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1941-7640</gtr:issn><gtr:outcomeId>58c1640d6f70a6.83248466</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7155A52B-6D9E-4705-B516-DC78C0C8A473</gtr:id><gtr:title>Human rhinovirus-induced inflammatory responses are inhibited by phosphatidylserine containing liposomes.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7dc1243ad2ca64eff23f5b38410209e0"><gtr:id>7dc1243ad2ca64eff23f5b38410209e0</gtr:id><gtr:otherNames>Stokes CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn><gtr:outcomeId>58c164686484a0.27073019</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6612FE57-8E79-406B-B306-E379FE2C421C</gtr:id><gtr:title>Pulmonary artery denervation reduces pulmonary artery pressure and induces histological changes in an acute porcine model of pulmonary hypertension.</gtr:title><gtr:parentPublicationTitle>Circulation. Cardiovascular interventions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74fbe7b47b55cb090b67e1778274ea66"><gtr:id>74fbe7b47b55cb090b67e1778274ea66</gtr:id><gtr:otherNames>Rothman AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1941-7640</gtr:issn><gtr:outcomeId>5aa15adf54e691.78824709</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_12022</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C4255A20-7C03-4147-BA26-8D72C9457F1C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>HRCS Health Uncodeable</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>06E85C67-BEDD-4C93-990D-B74FCF876924</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>HRCS Research Uncodeable</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>